The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Sahai, E., & Marshall, C. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc725 · Cited by 1,261
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A., & Downward, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80226-3 · Cited by 1,061
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
Understanding Ras: ‘it ain’t over ’til it’s over’
Shields, J. M., Pruitt, K., McFall, A., Shaub, A., & Der, C. J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01740-2 · Cited by 780
Self-citationBar-Sagi, D., & Hall, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00115-x · Cited by 779
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Multiple ras functions can contribute to mammalian cell transformation
White, M. A., Nicolette, C., Minden, A., Polverino, A., Aelst, L. V., Karin, M., & Wigler, M. H. (1995) · Cell · doi:10.1016/0092-8674(95)90507-3 · Cited by 649
Comparative biology of mouse versus human cells: modelling human cancer in mice
Rangarajan, A., & Weinberg, R. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1235 · Cited by 567
Genetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma
Tsao, H., Yang, G., Goel, V., Wu, H., & Haluska, F. G. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22243.x · Cited by 467
Raf proteins and cancer: B-Raf is identified as a mutational target
Mercer, K. E., & Pritchard, C. A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00016-7 · Cited by 457
The small GTPase RalA targets filamin to induce filopodia
Ohta, Y., Suzuki, N., Nakamura, S., Hartwig, J. H., & Stossel, T. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2122 · Cited by 453
The dark side of Ras: regulation of apoptosis
Cox, A. D., & Der, C. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207111 · Cited by 437
Self-citationDistinct requirements for Ras oncogenesis in human versus mouse cells
Hamad, N. M., Elconin, J. H., Karnoub, A. E., Bai, W., Rich, J. N., Abraham, R. T., Der, C. J., & Counter, C. M. (2002) · Genes & Development · doi:10.1101/gad.993902 · Cited by 431
Self-citationMechanisms of regulating the Raf kinase family
Chong, H., Vikis, H. G., & Guan, K.-L. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00139-0 · Cited by 405
The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., & White, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4309-4318.2002 · Cited by 393
Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours
Malliri, A., van der Kammen, R. A., Clark, K., van der Valk, M., Michiels, F., & Collard, J. G. (2002) · Nature · doi:10.1038/nature00848 · Cited by 384
Stimulation of Membrane Ruffling and MAP Kinase Activation by Distinct Effectors of RAS
Joneson, T., White, M. A., Wigler, M. H., & Bar-Sagi, D. (1996) · Science · doi:10.1126/science.271.5250.810 · Cited by 371
Phospholipase Cepsilon: a novel Ras effector
Kelley, G. G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.743 · Cited by 361
V599EB-RAF is an Oncogene in Melanocytes
Wellbrock, C., Ogilvie, L., Hedley, D., Karasarides, M., Martin, J., Niculescu-Duvaz, D., Springer, C. J., & Marais, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3433 · Cited by 344
Khosravi-Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska-Wodnicka, M., Van Aelst, L., Wigler, M. H., & Der, C. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3923 · Cited by 343
Self-citationBridging Ral GTPase to Rho Pathways
Jullien-Flores, V., Dorseuil, O., Romero, F., Letourneur, F., Saragosti, S., Berger, R., Tavitian, A., Gacon, G., & Camonis, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22473 · Cited by 338
Urano, T., Emkey, R., & Feig, L. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00416.x · Cited by 331
Rodriguez-Viciana, P., Sabatier, C., & McCormick, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4943-4954.2004 · Cited by 327
Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism
Lambert, J. M., Lambert, Q. T., Reuther, G. W., Malliri, A., Siderovski, D. P., Sondek, J., Collard, J. G., & Der, C. J. (2002) · Nature Cell Biology · doi:10.1038/ncb833 · Cited by 326
Self-citationGAP control: regulating the regulators of small GTPases
Bernards, A., & Settleman, J. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.05.003 · Cited by 310
Cantor, S. B., Urano, T., & Feig, L. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4578 · Cited by 310
Dreijerink, K., Braga, E., Kuzmin, I., Geil, L., Duh, F.-M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131216298 · Cited by 294
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo, K. W., Kwong, J., Hui, A. B., Chan, S. Y., To, K. F., Chan, A. S. Y., Chow, L. S. N., Teo, P., Johnson, P. J., & Huang, D. P. (2001) · PubMed · Cited by 290
Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis
Vos, M. D., Ellis, C. A., Bell, A., Birrer, M. J., & Clark, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000463200 · Cited by 289
Dammann, R., Yang, G., & Pfeifer, G. P. (2001) · PubMed · Cited by 280
Analysis of the transcriptional program induced by Raf in epithelial cells
Schulze, A., Lehmann, K., Jefferies, H. B. J., McMahon, M., & Downward, J. (2001) · Genes & Development · doi:10.1101/gad.191101 · Cited by 259
Ral-GTPases: approaching their 15 minutes of fame.
Feig, L. A. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00152-1 · Cited by 249
White, M. A., Vale, T., Camonis, J. H., Schaefer, E., & Wigler, M. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16439 · Cited by 240
Ral GTPases Regulate Exocyst Assembly through Dual Subunit Interactions
Moskalenko, S., Tong, C., Rosse, C., Mirey, G., Formstecher, E., Daviet, L., Camonis, J., & White, M. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308702200 · Cited by 238
In ovarian neoplasms, BRAF , but not KRAS , mutations are restricted to low‐grade serous tumours
Sieben, N. L., Macropoulos, P., Roemen, G. M., Kolkman‐Uljee, S. M., Jan Fleuren, G., Houmadi, R., Diss, T., Warren, B., Al Adnani, M., de Goeij, A. P., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1521 · Cited by 237
BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) Mutations in Distinct Subsets of Pancreatic Cancer
Calhoun, E. S., Jones, J. B., Ashfaq, R., Adsay, V., Baker, S. J., Valentine, V., Hempen, P. M., Hilgers, W., Yeo, C. J., Hruban, R. H., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63485-2 · Cited by 232
Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP
Matheny, S. A., Chen, C., Kortum, R. L., Razidlo, G. L., Lewis, R. E., & White, M. A. (2004) · Nature · doi:10.1038/nature02237 · Cited by 217
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
Gemignani, M. L., Schlaerth, A. C., Bogomolniy, F., Barakat, R. R., Lin, O., Soslow, R., Venkatraman, E., & Boyd, J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00264-6 · Cited by 213
Ortiz-Vega, S., Khokhlatchev, A., Nedwidek, M., Zhang, X.-F., Dammann, R., Pfeifer, G. P., & Avruch, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205192 · Cited by 209
Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis
Rytömaa, M., Martins, L. M., & Downward, J. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80454-0 · Cited by 208
A novel family ofras-binding domains
Ponting, C. P., & Benjamin, D. R. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)30038-8 · Cited by 205
Morrissey, C., Martinez, A., Zatyka, M., Agathanggelou, A., Honorio, S., Astuti, D., Morgan, N. V., Moch, H., Richards, F. M., Kishida, T., et al. (2001) · PubMed · Cited by 197
RAL GTPases are linchpin modulators of human tumour‐cell proliferation and survival
Chien, Y., & White, M. A. (2003) · EMBO reports · doi:10.1038/sj.embor.embor899 · Cited by 193
Jullien-Flores, V., Mahé, Y., Mirey, G., Leprince, C., Meunier-Bisceuil, B., Sorkin, A., & Camonis, J. H. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2837 · Cited by 186
RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor
Vos, M. D., Ellis, C. A., Elam, C., Ülkü, A. S., Taylor, B. J., & Clark, G. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300554200 · Cited by 183
Ras–effector interactions: after one decade
Herrmann, C. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00007-6 · Cited by 179
(1995) · PubMed · Cited by 178
Identification of Guanine Nucleotide Exchange Factors (GEFs) for the Rap1 GTPase
Rebhun, J. F., Castro, A. F., & Quilliam, L. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005327200 · Cited by 164
Stimulation of gene induction and cell growth by the Ras effector Rlf
Wolthuis, R. M. F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.22.6748 · Cited by 163
Ward, Y., Wang, W., Woodhouse, E., Linnoila, I., Liotta, L., & Kelly, K. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5958-5969.2001 · Cited by 161
Shipitsin, M. V., & Feig, L. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5746-5756.2004 · Cited by 152
Ikeda, M., Ishida, O., Hinoi, T., Kishida, S., & Kikuchi, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.814 · Cited by 146
Oldham, S., Clark, G. J., Gangarosa, L. M., Coffey, R. J., & Der, C. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6924 · Cited by 142
Self-citationByun, D.-S., Lee, M., Chae, K. S., Ryu, B. G., & Chi, S. G. (2001) · PubMed · Cited by 138
Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee, M., Kim, H. Y., Byun, D.-S., Lee, S., Lee, C. H., Kim, J. I., Chang, S., & Chi, S. G. (2001) · PubMed · Cited by 134
An EGF receptor/Ral‐GTPase signaling cascade regulates c‐Src activity and substrate specificity
Goi, T., Shipitsin, M. V., Lu, Z., Foster, D. A., Klinz, S. G., & Feig, L. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.623 · Cited by 133
NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers
Hesson, L. B., Dallol, A., Minna, J. D., Maher, E. R., & Latif, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206191 · Cited by 130
An Eps Homology (EH) Domain Protein That Binds to the Ral-GTPase Target, RalBP1
Yamaguchi, A., Urano, T., Goi, T., & Feig, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31230 · Cited by 126
The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the Lung
Vos, M. D., Martínez, A., Ellis, C. A., Vallecorsa, T., & Clark, G. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211019200 · Cited by 125
McFall, A., ülkuü, A., Lambert, Q. T., Kusa, A., Rogers-Graham, K., & Der, C. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5488-5499.2001 · Cited by 120
Self-citationTommasi, S., Dammann, R., Jin, S., Zhang, X., Avruch, J., & Pfeifer, G. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205365 · Cited by 115
Protein binding and signaling properties of RIN1 suggest a unique effector function
Han, L., Wong, D., Dhaka, A., Afar, D., White, M. A., Xie, W., Herschman, H. R., Witte, O. N., & Colicelli, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4954 · Cited by 114
Chen, J., Lui, W., Vos, M. D., Clark, G. J., Takahashi, M., Schoumans, J., Khoo, S. K., Petillo, D., Lavery, T. T., Sugimura, J., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00269-1 · Cited by 114
Ral GTPases Contribute to Regulation of Cyclin D1 through Activation of NF-κB
Henry, D. O., Moskalenko, S. A., Kaur, K. J., Fu, M., Pestell, R. G., Camonis, J., & White, M. A. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.21.8084-8092.2000 · Cited by 105
de Ruiter, N. D., Burgering, B. M. T., & Bos, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8225-8235.2001 · Cited by 100
Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases
Aoyama, Y., Avruch, J., & Zhang, X. (2004) · Oncogene · doi:10.1038/sj.onc.1207486 · Cited by 94
Arcaro, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.805 · Cited by 92
Liao, Y., Kariya, K., Hu, C., Shibatohge, M., Goshima, M., Okada, T., Watari, Y., Gao, X., Jin, T. J., Yamawaki‐Kataoka, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37815 · Cited by 87
de Ruiter, N. D., Wolthuis, R. M. F., van Dam, H., Burgering, B. M. T., & Bos, J. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8480-8488.2000 · Cited by 80
Uncoupling Raf1 from MEK1/2 Impairs Only a Subset of Cellular Responses to Raf Activation
Pearson, G. W., Bumeister, R., Henry, D. O., Cobb, M. H., & White, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000570200 · Cited by 72
BRAF and K-ras gene mutations in human pancreatic cancers
Ishimura, N., Yamasawa, K., Rumi, M. A. K., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00384-7 · Cited by 70
Ras‐binding domains: predicting function versus folding
Kalhammer, G., Bähler, M., Schmitz, F., Jöckel, J., & Block, C. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01076-4 · Cited by 42
The RASputin effect: Figure 1.Preprint
Boettner, B., & Aelst, L. V. (2002) · Genes & Development · doi:10.1101/gad.1020602 · Cited by 27
Ulkü, A. S., Schäfer, R., & Der, C. J. (2003) · PubMed · Cited by 21
Self-citation
Cited by
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
Roberts, P. J., & Der, C. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210422 · Cited by 2,788
Self-citationHyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
The Ras superfamily at a glance
Wennerberg, K., Rossman, K. L., & Der, C. J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01660 · Cited by 1,352
Self-citationCoordinating ERK/MAPK signalling through scaffolds and inhibitors
Kolch, W. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1743 · Cited by 1,070
Singh, A., Greninger, P., Rhodes, D., Koopman, L., Violette, S., Bardeesy, N., & Settleman, J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.022 · Cited by 841
Metadata
- Authors
- Repasky, G. A., Chenette, E. J., & Der, C. J.
- Venue
- Trends in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 14
- Issue
- 11
- Pages
- 639-647
- ISSN
- 0962-8924 (ISSN-L)
- OpenAlex
- W1995216176
- Cited by
- 300
- References
- 84
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.